Patents Assigned to Formulations Development Labs
  • Patent number: 4918103
    Abstract: A pharmaceutically elegant, one phase, liquid composition for oral administration comprises a NSAID such as ibuprofen plus a di- or triglyceride of a medium chain fatty acid edible oil which has the characteristics of a pharmaceutical solvent carrier as known to those skilled in the art. Other pharmaceutical additives may be optionally added. An additional stipulation is that ethanol or other monohydric alcohol solvents should not be present.
    Type: Grant
    Filed: July 25, 1988
    Date of Patent: April 17, 1990
    Assignee: Formulations Development Labs
    Inventors: Moo K. Park, Henry C. Caldwell
  • Patent number: 4880835
    Abstract: Pharmaceutically elegant oral liquid compositions of sulindac are prepared using calcium sulindac in a vehicle comprising a glycol, a polyol, optional ethanol and pharmaceutical additives.
    Type: Grant
    Filed: November 3, 1988
    Date of Patent: November 14, 1989
    Assignee: Formulations Development Labs, Inc.
    Inventor: Moo K. Park